Type 2 Diabetes and In-hospital Complications After Revision of Total Hip and Knee Arthroplasty

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Aug 25

PMID 28837689

Citations 12

Authors

Ana Lopez-de-Andres

Valentin Hernandez-Barrera

Maria A Martinez-Huedo

Manuel Villanueva-Martinez

Isabel Jimenez-Trujillo

Rodrigo Jimenez-Garcia

Affiliations

Soon will be listed here.

Abstract

Purpose: To assess the effect of type 2 diabetes (T2DM) on hospital outcomes such as in hospital postoperative complications (IHPC), length of hospital stay (LOHS) and in-hospital mortality (IHM) after the revision of total hip arthroplasty (RHA) and total knee arthroplasty (RKA) and to identify factors associated with IHPC among T2DM patients undergoing these procedures.

Methods: We performed a retrospective study using the Spanish National Hospital Discharge Database, 2005-2014. We included patients who were ≥40 years old that had undergone RHA and RKA. For each T2DM patient, we selected a year-, gender-, age- and Charlson Comorbidity Index-matched non-diabetic patient.

Results: We identified 44,055 and 39,938 patients who underwent RHA (12.72% with T2DM) and RKA (15.01% with T2DM). We matched 4,700 and 5,394 couples with RHA and RKA, respectively. Any IHPC was more frequent among patients with T2DM than among non-T2DM patients (19% vs. 15.64% in the RHA cohort and 12.94% vs. 11.09% in the RKA cohort, respectively). For patients who underwent RHA, postoperative infection (4.51% vs. 2.94%, p<0.001), acute post-hemorrhagic anemia (9.53% vs. 7.70%, p<0.001), mean LOHS and IHM were significantly higher in patients with T2DM. Among RKA patients, the incidence of acute posthemorrhagic anemia (7.21% vs. 5.62%; p = 0.001) and urinary tract infection (1.13% vs. 0.72%; p = 0.029) was significantly higher in patients with diabetes. Older age, obesity, infection due to internal joint prosthesis, myocardial infarction, congestive heart failure, mild liver disease and renal disease and emergency room admission were significantly associated with a higher risk of IHPC in T2DM patients. IHPC decreased over time only in T2DM patients who underwent RHA (OR 0.94, 95%CI 0.89-0.98).

Conclusions: Patients with T2DM who underwent RHA and RKA procedures had more IHPC after controlling for the effects of possible confounders. LOHS and IHM were also higher among RHA patients with diabetes. Older age, comorbidity, obesity and emergency room admission were strong predictors of IHPC in diabetic patients.

Citing Articles

Role of insulin-dependent and non-insulin-dependent diabetes in aseptic revision total shoulder arthroplasty.

Loyst R, Liu S, Cerri-Droz P, Leatherwood W, Komatsu D, Wang E Eur J Orthop Surg Traumatol. 2024; 34(5):2511-2516.

PMID: 38668774 DOI: 10.1007/s00590-024-03954-2.

Effect of Preoperative Corticosteroids on Postoperative Glucose Control in Total Joint Arthroplasty.

Denyer S, Ramini A, Eikani C, Murphy M, Brown N Arthroplast Today. 2023; 24:101238.

PMID: 38077928 PMC: 10700152. DOI: 10.1016/j.artd.2023.101238.

Aljuhani W, Alanazi A, Saeed A, Alhadlaq K, Alhoshan Y, Aljaafri Z J Orthop Surg Res. 2023; 18(1):717.

PMID: 37736732 PMC: 10514936. DOI: 10.1186/s13018-023-04210-9.

Postoperative short-term mortality between insulin-treated and non-insulin-treated patients with diabetes after non-cardiac surgery: a systematic review and meta-analysis.

Jiang J, Wang S, Sun R, Zhao Y, Zhou Z, Bi J Front Med (Lausanne). 2023; 10:1142490.

PMID: 37200964 PMC: 10185903. DOI: 10.3389/fmed.2023.1142490.

A mapping review on preoperative prognostic factors and outcome measures of revision total knee arthroplasty.

Belt M, Robben B, Smolders J, Schreurs B, Hannink G, Smulders K Bone Jt Open. 2023; 4(5):338-356.

PMID: 37160269 PMC: 10169239. DOI: 10.1302/2633-1462.45.BJO-2022-0157.R1.

References

Chun Y, Lee S, Lee S, Cho Y, Rhyu K . Clinical Implication of Diabetes Mellitus in Primary Total Hip Arthroplasty. Hip Pelvis. 2016; 26(3):136-42. PMC: 4971138. DOI: 10.5371/hp.2014.26.3.136. View

Namba R, Cafri G, Khatod M, Inacio M, Brox T, Paxton E . Risk factors for total knee arthroplasty aseptic revision. J Arthroplasty. 2013; 28(8 Suppl):122-7. DOI: 10.1016/j.arth.2013.04.050. View

Schmidt M, Schmidt S, Sandegaard J, Ehrenstein V, Pedersen L, Sorensen H . The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015; 7:449-90. PMC: 4655913. DOI: 10.2147/CLEP.S91125. View

King K, Findley T, Williams A, Bucknell A . Veterans with diabetes receive arthroplasty more frequently and at a younger age. Clin Orthop Relat Res. 2013; 471(9):3049-54. PMC: 3734424. DOI: 10.1007/s11999-013-3026-3. View

Viola J, Gomez M, Restrepo C, Maltenfort M, Parvizi J . Preoperative anemia increases postoperative complications and mortality following total joint arthroplasty. J Arthroplasty. 2015; 30(5):846-8. DOI: 10.1016/j.arth.2014.12.026. View

Villanueva-Martinez M, Hernandez-Barrera V, Chana-Rodriguez F, Rojo-Manaute J, Rios-Luna A, San Roman Montero J . Trends in incidence and outcomes of revision total hip arthroplasty in Spain: a population based study. BMC Musculoskelet Disord. 2012; 13:37. PMC: 3349558. DOI: 10.1186/1471-2474-13-37. View

Fu A, Iglay K, Qiu Y, Engel S, Shankar R, Brodovicz K . Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes. J Diabetes Complications. 2014; 28(6):805-10. DOI: 10.1016/j.jdiacomp.2014.06.009. View

Jiang J, Southern D, Beck C, James M, Lu M, Quan H . Validity of Canadian discharge abstract data for hypertension and diabetes from 2002 to 2013. CMAJ Open. 2016; 4(4):E646-E653. PMC: 5173472. DOI: 10.9778/cmajo.20160128. View

Antwi-Bafour S, Hammond S, Adjei J, Kyeremeh R, Martin-Odoom A, Ekem I . A case-control study of prevalence of anemia among patients with type 2 diabetes. J Med Case Rep. 2016; 10(1):110. PMC: 4855820. DOI: 10.1186/s13256-016-0889-4. View

10.

Ribera A, Marsal J, Ferreira-Gonzalez I, Cascant P, Pons J, Mitjavila F . Predicting in-hospital mortality with coronary bypass surgery using hospital discharge data: comparison with a prospective observational study. Rev Esp Cardiol. 2008; 61(8):843-52. View

11.

Labek G, Thaler M, Janda W, Agreiter M, Stockl B . Revision rates after total joint replacement: cumulative results from worldwide joint register datasets. J Bone Joint Surg Br. 2011; 93(3):293-7. DOI: 10.1302/0301-620X.93B3.25467. View

12.

Hamilton D, Howie C, Burnett R, Simpson A, Patton J . Dealing with the predicted increase in demand for revision total knee arthroplasty: challenges, risks and opportunities. Bone Joint J. 2015; 97-B(6):723-8. DOI: 10.1302/0301-620X.97B6.35185. View

13.

Marchant Jr M, Viens N, Cook C, Vail T, Bolognesi M . The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009; 91(7):1621-9. DOI: 10.2106/JBJS.H.00116. View

14.

Khokhar B, Jette N, Metcalfe A, Cunningham C, Quan H, Kaplan G . Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations. BMJ Open. 2016; 6(8):e009952. PMC: 4985868. DOI: 10.1136/bmjopen-2015-009952. View

15.

Kamath A, Ong K, Lau E, Chan V, Vail T, Rubash H . Quantifying the Burden of Revision Total Joint Arthroplasty for Periprosthetic Infection. J Arthroplasty. 2015; 30(9):1492-7. DOI: 10.1016/j.arth.2015.03.035. View

16.

Koenig K, Huddleston 3rd J, Huddleston H, Maloney W, Goodman S . Advanced age and comorbidity increase the risk for adverse events after revision total hip arthroplasty. J Arthroplasty. 2012; 27(7):1402-1407.e1. DOI: 10.1016/j.arth.2011.11.013. View

17.

Jamsen E, Peltola M, Eskelinen A, Lehto M . Comorbid diseases as predictors of survival of primary total hip and knee replacements: a nationwide register-based study of 96 754 operations on patients with primary osteoarthritis. Ann Rheum Dis. 2012; 72(12):1975-82. PMC: 3841739. DOI: 10.1136/annrheumdis-2012-202064. View

18.

Soriguer F, Goday A, Bosch-Comas A, Bordiu E, Calle-Pascual A, Carmena R . Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2011; 55(1):88-93. PMC: 3228950. DOI: 10.1007/s00125-011-2336-9. View

19.

Sams J, Francis M, Scaife S, Robinson B, Novicoff W, Saleh K . Redefining revision total hip arthroplasty based on hospital admission status. J Arthroplasty. 2011; 27(5):758-63. DOI: 10.1016/j.arth.2011.09.007. View

20.

Houdek M, Wagner E, Watts C, Osmon D, Hanssen A, Lewallen D . Morbid obesity: a significant risk factor for failure of two-stage revision total hip arthroplasty for infection. J Bone Joint Surg Am. 2015; 97(4):326-32. DOI: 10.2106/JBJS.N.00515. View